SCHEDULE 13G/A

AKERO THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 00973Y108

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• General Atlantic, L.P.

  Shares: 6,796,489.00 · Class: 8.4%

• General Atlantic Partners 100, L.P.

  Shares: 5,233,989.00 · Class: 6.5%

• GAP Coinvestments III, LLC

  Shares: 6,796,489.00 · Class: 8.4%

• GAP Coinvestments IV, LLC

  Shares: 6,796,489.00 · Class: 8.4%

• GAP Coinvestments V, LLC

  Shares: 6,796,489.00 · Class: 8.4%

• GAP Coinvestments CDA, L.P.

  Shares: 6,796,489.00 · Class: 8.4%

• General Atlantic (SPV) GP, LLC

  Shares: 5,233,989.00 · Class: 6.5%

• General Atlantic GenPar (Bermuda), L.P.

  Shares: 6,796,489.00 · Class: 8.4%

• General Atlantic GenPar, L.P.

  Shares: 5,233,989.00 · Class: 6.5%

• General Atlantic (AK), L.P.

  Shares: 5,233,989.00 · Class: 6.5%

• GAP (Bermuda) L.P.

  Shares: 6,796,489.00 · Class: 8.4%

• General Atlantic (Lux) S.a.r.l.

  Shares: 6,796,489.00 · Class: 8.4%

• General Atlantic GenPar (Lux) SCSp

  Shares: 6,796,489.00 · Class: 8.4%

• General Atlantic Partners (Lux) SCSp

  Shares: 6,796,489.00 · Class: 8.4%

• General Atlantic Partners (Bermuda) AK, L.P.

  Shares: 1,562,500.00 · Class: 1.9%

• General Atlantic (SPV) GP (Bermuda), LLC

  Shares: 1,562,500.00 · Class: 1.9%

• General Atlantic Partners (Bermuda) IV, L.P.

  Shares: 1,562,500.00 · Class: 1.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.